October 21st 2022
Evan J. Lipson, MD, discusses the effect of preoperative nivolumab plus relatlimab in resectable non-small cell lung cancer (NSCLC).
June 30th 2022
Evan J. Lipson, MD, discusses the current treatment landscape in locally advanced, unresectable, or metastatic basal cell carcinoma.
December 8th 2021
Evan J. Lipson, MD, discusses the role of circulating tumor DNA testing in melanoma.
December 14th 2020